Comparison of incretin-related drugs (GLP-1 receptor agonists and DPP IV inhibitors) and insulin for clinical effects in patients with type 2 diabetes mellitus
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000009690
- Lead Sponsor
- Division of Endocrinology and Metabolism, Jichi Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1)severe ketosis, diabetic coma within 6 months 2)severe infection, before operation, severe trauma 3)pregnacy 4)liver cirrhosis, chronic renal failure (serum creatinine level>2.0mg/dL), respiratory failure 5)allergy for liraglutide, alogliptin and glargine 6)patients judged by the investigator to be ineligible for some other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change of HbA1c and BW (body mass index)
- Secondary Outcome Measures
Name Time Method